0.05Open0.25Pre Close1 Volume4 Open Interest2.50Strike Price5.00Turnover413.55%IV248.84%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier17DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1921Delta0.4014Gamma14.63Leverage Ratio-0.0053Theta0.0000Rho2.81Eff Leverage0.0004Vega
PAVmed Stock Discussion
PR Newswire· 6 mins ago
The incubator, PMX, and medical device firm Hatch Medical, execute joint venture agreement to complete their development and commercialization, starting with PortIO
NEW YORK, March 21, 2024 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical de...
No comment yet